Polysulfated Glycosaminoglycan side effects in Thoroughbreds

63 FDA reports involve Polysulfated Glycosaminoglycan in a Thoroughbred. These are the problems they describe.

34 54%

28 44%

16 25%

11 17%

Leucocytosis

8 13%

Abnormal ultrasound finding

7 11%

Elevated fibrinogen level

7 11%

Stiffness

6 9.5%

Lymphopenia

6 9.5%

6 9.5%

Reluctant to move

5 7.9%

Serum amyloid a high, blood

4 6.3%